Litigation
Intas Pharmaceuticals Ltd. v. Atossa Therapeutics, Inc. et al.
SettledIPR2025-00799
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Terminated
- 2026-04-16
Patents at issue (1)
Plaintiffs (1)
Defendants (2)
Summary
Intas Pharmaceuticals Ltd. filed an Inter Partes Review (IPR) against Atossa Therapeutics, Inc. and Jina Pharmaceuticals, Inc. at the PTAB, challenging US patent 11261151. The parties settled on April 16, 2026, leading to the termination of the PTAB proceedings.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).